© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
EDAP TMS S.A. American Depositary Shares (FOCL) stock declined over -0.24%, trading at $4.20 on NASDAQ, down from the previous close of $4.21. The stock opened at $4.12, fluctuating between $4.12 and $4.26 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 4.12 | 4.26 | 4.12 | 4.20 | 87.4K |
| Sep 08, 2026 | 4.16 | 4.30 | 4.11 | 4.21 | 109.69K |
| Sep 04, 2026 | 4.18 | 4.24 | 4.15 | 4.15 | 102.83K |
| Sep 03, 2026 | 4.27 | 4.40 | 4.17 | 4.17 | 32.07K |
| Sep 02, 2026 | 4.30 | 4.35 | 4.17 | 4.22 | 112.98K |
| Sep 01, 2026 | 4.26 | 4.38 | 4.21 | 4.31 | 71.24K |
| Aug 31, 2026 | 4.31 | 4.38 | 4.25 | 4.27 | 18.65K |
| Aug 28, 2026 | 4.39 | 4.47 | 4.30 | 4.31 | 30.37K |
| Aug 27, 2026 | 4.42 | 4.50 | 4.30 | 4.34 | 81.11K |
| Aug 26, 2026 | 4.35 | 4.49 | 4.28 | 4.41 | 57.83K |
| Aug 25, 2026 | 4.12 | 4.47 | 4.12 | 4.39 | 55.04K |
| Aug 24, 2026 | 4.18 | 4.24 | 4.01 | 4.18 | 129.97K |
| Aug 21, 2026 | 4.23 | 4.24 | 4.08 | 4.13 | 236.36K |
| Aug 20, 2026 | 4.30 | 4.34 | 4.22 | 4.24 | 175.91K |
| Aug 19, 2026 | 4.26 | 4.49 | 4.20 | 4.36 | 218.07K |
| Aug 18, 2026 | 4.39 | 4.50 | 4.09 | 4.26 | 339.75K |
| Aug 17, 2026 | 4.82 | 4.82 | 4.21 | 4.36 | 463.88K |
| Aug 14, 2026 | 4.51 | 4.78 | 4.51 | 4.76 | 355.83K |
| Aug 13, 2026 | 4.70 | 4.93 | 4.53 | 4.63 | 308.54K |
| Aug 12, 2026 | 4.75 | 5.01 | 4.67 | 4.75 | 1.29M |
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
| Employees | 289 |
| Beta | -0.03 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Devices |